Literature DB >> 10723136

Somatic mutagenesis studies of NF-kappa B signaling in human T cells: evidence for an essential role of IKK gamma in NF-kappa B activation by T-cell costimulatory signals and HTLV-I Tax protein.

E W Harhaj1, L Good, G Xiao, M Uhlik, M E Cvijic, I Rivera-Walsh, S C Sun.   

Abstract

NF-kappa B plays a pivotal role in normal T-cell activation and may also mediate human T-cell leukemia virus (HTLV)-induced T-cell transformation. Activation of NF-kappa B by both T-cell costimulatory signals and the HTLV Tax protein involves stimulation of I kappa B kinase (IKK). As a genetic approach to dissect the intermediate steps involved in NF-kappa B activation in human T cells, we performed somatic cell mutagenesis to isolate signaling-defective mutant Jurkat T-cell lines. One of the mutant cell lines was shown to have a specific blockade in the IKK signaling pathway but remained competent in the c-Jun N-terminal kinase and MAP kinase pathways. Interestingly, this mutant cell line lacks expression of IKK gamma, a non-catalytic component of the IKK complex. Expression of exogenous IKK gamma in the mutant cells restored NF-kappa B activation by both the T-cell costimulation agents and Tax. These findings provide genetic evidence for the requirement of IKK gamma in NF-kappa B signaling triggered by both T-cell costimulatory signals and HTLV-I Tax protein.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10723136     DOI: 10.1038/sj.onc.1203445

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  39 in total

1.  Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha.

Authors:  G Xiao; M E Cvijic; A Fong; E W Harhaj; M T Uhlik; M Waterfield; S C Sun
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

Review 2.  Hostile takeovers: viral appropriation of the NF-kappaB pathway.

Authors:  J Hiscott; H Kwon; P Génin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

3.  Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-kappaB in the absence of NF-kappaB essential modifier residues 133-224 or 373-419.

Authors:  Daniela Boehm; Benjamin E Gewurz; Elliott Kieff; Ellen Cahir-McFarland
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-05       Impact factor: 11.205

4.  NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling.

Authors:  S Kreuz; D Siegmund; P Scheurich; H Wajant
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

Review 5.  An enigmatic tail of CD28 signaling.

Authors:  Jonathan S Boomer; Jonathan M Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-09       Impact factor: 10.005

6.  The human T-cell leukemia virus type-1 tax oncoprotein dissociates NF-κB p65RelA-Stathmin complexes and causes catastrophic mitotic spindle damage and genomic instability.

Authors:  Aditi Malu; Tetiana Hutchison; Laçin Yapindi; Katie Smith; Katherine Nelson; Rachel Bergeson; Jordan Pope; Megan Romeo; Carolyn Harrod; Lee Ratner; Carine Van Lint; Robert Harrod
Journal:  Virology       Date:  2019-07-03       Impact factor: 3.616

7.  Vitamin D does not modulate NF-kappaB activity in Jurkat T cells.

Authors:  Amde Selassie Shifera; Deborah Leong; John A Hardin
Journal:  Immunol Lett       Date:  2010-04-10       Impact factor: 3.685

8.  NF-kappaB signals induce the expression of c-FLIP.

Authors:  O Micheau; S Lens; O Gaide; K Alevizopoulos; J Tschopp
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

9.  A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells.

Authors:  Kai-Li He; Adrian T Ting
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

10.  NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain.

Authors:  E Laplantine; E Fontan; J Chiaravalli; T Lopez; G Lakisic; M Véron; F Agou; Alain Israël
Journal:  EMBO J       Date:  2009-09-17       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.